HomeCompareRYZZ vs JNJ

RYZZ vs JNJ: Dividend Comparison 2026

RYZZ yields 9.37% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RYZZ wins by $17.2K in total portfolio value
10 years
RYZZ
RYZZ
● Live price
9.37%
Share price
$21.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.2K
Annual income
$1,691.64
Full RYZZ calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RYZZ vs JNJ

📍 RYZZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRYZZJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RYZZ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RYZZ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYZZ
Annual income on $10K today (after 15% tax)
$796.78/yr
After 10yr DRIP, annual income (after tax)
$1,437.89/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RYZZ beats the other by $734.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYZZ + JNJ for your $10,000?

RYZZ: 50%JNJ: 50%
100% JNJ50/50100% RYZZ
Portfolio after 10yr
$28.6K
Annual income
$1,259.71/yr
Blended yield
4.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RYZZ
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYZZ buys
0
JNJ buys
0
No recent congressional trades found for RYZZ or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRYZZJNJ
Forward yield9.37%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$37.2K$20.0K
Annual income after 10y$1,691.64$827.78
Total dividends collected$13.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RYZZ vs JNJ ($10,000, DRIP)

YearRYZZ PortfolioRYZZ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,637$937.39$10,676$355.77+$961.00RYZZ
2$13,472$1,019.51$11,407$389.39+$2.1KRYZZ
3$15,518$1,102.99$12,198$426.53+$3.3KRYZZ
4$17,791$1,187.39$13,056$467.62+$4.7KRYZZ
5$20,309$1,272.30$13,987$513.12+$6.3KRYZZ
6$23,088$1,357.33$14,998$563.56+$8.1KRYZZ
7$26,146$1,442.12$16,098$619.52+$10.0KRYZZ
8$29,503$1,526.30$17,295$681.69+$12.2KRYZZ
9$33,177$1,609.57$18,599$750.82+$14.6KRYZZ
10$37,191$1,691.64$20,022$827.78+$17.2KRYZZ

RYZZ vs JNJ: Complete Analysis 2026

RYZZStock

The investment seeks positive absolute and risk-adjusted returns. The fund is an actively-managed exchange-traded fund ("ETF"). It seeks to achieve its investment objective by blending a dynamic equity strategy with complementary long/short managed futures strategies that seek to achieve positive returns that have a low correlation to the overall economic environment, and that have a relatively low correlation to more traditional index-based and long-only investment strategies. The fund implements its strategy using proprietary quantitative models that seek to identify repeatable price and volatility patterns in the markets in which it will trade.

Full RYZZ Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RYZZ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYZZ vs SCHDRYZZ vs JEPIRYZZ vs ORYZZ vs KORYZZ vs MAINRYZZ vs ABBVRYZZ vs MRKRYZZ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.